Evidence map›Paper›PMID 40234374›Full record

ArticleAnnals of nuclear medicine2025

Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?

Norikazu Matsutomo, Mitsuha Fukami, Tomoaki Yamamoto

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Norikazu MatsutomoDepartment of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, B- 524, 5 - 4- 1 Shimorenjaku Mitaka-shi, Tokyo, 181 - 8612, Japan. nmatsutomo@ks.kyorin-u.ac.jp.ORCID http://orcid.org/0000-0002-9691-9702
Mitsuha FukamiDepartment of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, B- 524, 5 - 4- 1 Shimorenjaku Mitaka-shi, Tokyo, 181 - 8612, Japan.
Tomoaki YamamotoDepartment of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, B- 524, 5 - 4- 1 Shimorenjaku Mitaka-shi, Tokyo, 181 - 8612, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the accuracy and validity of patient explanations about nuclear medicine examinations generated in Japanese using ChatGPT- 3.5 and ChatGPT- 4.

methodsChatGPT was used to generate Japanese language explanations for seven single-photon emission computed tomography examinations (bone scintigraphy, brain perfusion imaging, myocardial perfusion imaging, dopamine transporter scintigraphy [DAT scintigraphy], sentinel lymph node scintigraphy, lung perfusion scintigraphy, and renal function scintigraphy) and

resultsChatGPT- 4 demonstrated significantly higher accuracy and validity than ChatGPT- 3.5, with 77.9% of responses rated as above average or excellent for accuracy, in comparison to 36.3% for ChatGPT- 3.5. For validity, 73.1% of ChatGPT- 4's responses were rated as above average or excellent, in comparison to 19.6% for ChatGPT- 3.5. ChatGPT- 4 outperformed ChatGPT- 3.5 in all examinations, with notable improvements in bone scintigraphy, lung perfusion scintigraphy, and DAT scintigraphy.

conclusionThese findings suggest that ChatGPT- 4 can be a valuable tool for providing patient explanations of nuclear medicine examinations. However, its application still requires expert supervision, and further research is needed to address potential risks and security concerns.

Indexed as

Artificial IntelligenceNuclear MedicinePatient Education as TopicEast Asian PeopleHumansJapanArtificial intelligenceChatbotClinical supportPatient explanations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.